United States· US:72485-205_dad6f70f-70c9-4152-bd36-9cb3537239da

Capecitabine 500mg

A capecitabine product containing capecitabine, registered in United States by Armas Pharmaceuticals Inc.. The same ATC class is registered in 17 of our 19 countries.

ATC L01BC06US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about capecitabineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Capecitabine is registered in 17 of 19 countries.

Countries holding a registration under ATC L01BC06 (capecitabine), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
10 of them publish a price we can compare per daily dose

Search capecitabine products by name

Capecitabine · ATC L01BC06

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of capecitabine costs, country by country.

Normalised to the WHO defined daily dose (3 g), the median price runs from $2.73 in United States to $15.27 in Switzerland — a ×5.6 gap.

United States: $2.73 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Capecitabine · price per daily dose (3 g)

USD · FX 28 Sept 2026

CH Switzerland$15.27
IT Italy$12.14
FR France$8.39
US United States$2.73 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: CAPECITABINE
Manufacturer: Armas Pharmaceuticals Inc.
Country: United States (US)
ATC code: L01BC06
ATC class: Capecitabine
Defined daily dose: 3 g, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
7248520512
1 BOTTLE in 1 CARTON (72485-205-12) / 120 TABLET, FILM COATED in 1 BOTTLE
ndc11
72485-205-12

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

366 interactions on record for capecitabine.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check capecitabine against other medicines How interaction checks work

Capecitabine · interactions on record

366 records

35 severe
103 moderate
27 minor
200 info

Most severe, free to view

DicoumarolB01AA01severe
WarfarinB01AA03severe
Folic acidB03BB01severe
CladribineL01BB04severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Capecitabine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All capecitabine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Capecel, Capecitabin Sandoz
Bulgaria · Капецитабин Алуфарма, Капецитабин Зентива К.С
Cyprus · Capecitabine Koanaa 150mg, Capecitabine Koanaa 500mg
Czechia · Capecitabine, Capecitabine Pharmagen
Germany · Capecitabin Al, Capecitabin Amarox
Denmark · Capecitabin Stada, Capecitabin Zentiva
Estonia · Capecitabine Zentiva, Capecitabine Zentiva K.S.
Spain · Capecitabina Glenmark, Capecitabina Kern Pharma
Finland · Capecitabine Orion
France · Capecitabine Arrow, Capecitabine Biogaran
United Kingdom (Northern Ireland) · Capecitabine Amarox, Capecitabine Dr. Reddy's
Greece · Capecitabine Mylan, Capibine
Croatia · Kapecitabin Jgl 500 Mg, Kapecitabin Sandoz
Hungary · Capecitabin Onkogen, Capecitabine Pharmacenter
Iceland · Capecitabine Accord, Capecitabine Medac
Italy · Capecitabina Mylan, Capecitabina Zentiva
Liechtenstein · Capecitabine Accord, Capecitabine Medac
Lithuania · Capecitabine Zentiva, Capecitabine Zentiva K.S.
Latvia · Capecitabine Zentiva, Capecitabine Zentiva K.S.
Malta · Capecitabine Pharmacare, Kapetral
Netherlands · Capecitabine Amarox, Capecitabine Cf
Norway · Capecitabine Accord, Capecitabine Medac
Poland · Capecitabine Glenmark
Portugal · Capecitabina Aurovitas, Capecitabina Farmoz
Romania · Capecitabină Dr. Reddy's, Cerex
Sweden · Capecitabin Stada, Capecitabine Orion
Slovenia · Kapecitabin Fresenius Kabi
Slovakia · Capecitabine Pharmacenter, Capecitabine Pharmagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/da572589-9374-4bf5-96cc-c8dfca874492
GET /v1/drugs/da572589-9374-4bf5-96cc-c8dfca874492?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "500",
  "substance": "CAPECITABINE",
  "productndc": "72485-205",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA207456",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about capecitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console